NCT06120504CompletedPhase 1
A safety study of PF-08046045/SGN-35T in adults with advanced cancers
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Aug 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 10 Jan 2024
- Start date
- 20 Jun 2024
- Lead sponsor
- Seagen Inc.
- NCT number
- NCT06120504
- EU CT number
- 2022-502390-41-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 35
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH Coordinator of this site? Confirm its status | Berlin | Germany | Completed |
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen Oe | Denmark | Completed |
| Institut Catala D'oncologia Coordinator of this site? Confirm its status | L'Hospitalet de Llobregat | Spain | Completed |
| Hospital Universitario Fundación Jiménez Díaz Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo Alessandria Coordinator of this site? Confirm its status | Alexandria | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.